Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer

Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer

Colorectal cancer (CRC) is one of the most common aggressive carcinoma types worldwide, characterized by unfavorable curative effect and poor prognosis. Epidemiological data re-vealed that CRC risk is increased in patients with metabolic syndrome (MetS) and its serum components (e.g., hyperglycemia)...

Full description

Bibliographic Details
Main Author:	Aldona Kasprzak
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	International Journal of Molecular Sciences
Subjects:	insulin-like growth factor 1 (IGF-1) glucose metabolism metabolic risk factors colorectal cancer Warburg effect therapeutic strategies regulating insulin/IGF-1 signaling
Online Access:	https://www.mdpi.com/1422-0067/22/12/6434

Similar Items

The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer
by: Haim Werner, et al.
Published: (2021-04-01)

Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells
by: Şeyda Berk, et al.
Published: (2021-07-01)

Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports
by: Julian Bailes, et al.
Published: (2021-02-01)

The Insulin/IGF system in colorectal cancer development and resistance to therapy
by: Paolo Giovanni Vigneri, et al.
Published: (2015-10-01)

A novel heterozygous IGF-1 receptor mutation associated with hypoglycemia
by: R Solomon-Zemler, et al.
Published: (2017-08-01)

Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns
by: Rive Sarfstein, et al.
Published: (2020-07-01)

Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer—From Basic Research to Potential Clinical Applications
by: Aldona Kasprzak, et al.
Published: (2019-10-01)

A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptor
by: Fa Zhang, et al.
Published: (2021-11-01)

The effects of lycopene supplementation on serum insulin-like growth factor 1 (IGF-1) levels and cardiovascular disease: A dose-response meta-analysis of clinical trials
by: Zhihong Xie, et al.
Published: (2021-01-01)

Insulin-like Growth Factors (IGFs) and their binding proteins (IGFBPs) as biomarkers of catabolism
by: Nedić Olgica, et al.
Published: (2007-01-01)

Behçet’s syndrome and relationship with the ratio of insulin-like growth factor-1 (IGF-1)/IGF-binding protein-3 (IGFBP-3)
by: Özlem Doğan, et al.
Published: (2019-06-01)

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway
by: Haim Werner, et al.
Published: (2018-02-01)

Impact of insulin like growth factor-1 in development of coronary artery ectasia
by: Ibrahim Faruk Akturk, et al.
Published: (2014-09-01)

IGF1/IGF1R MITOGENIC PATHWAYS AND IMPLICATIONS IN GB THERAPY
by: Oana Alexandru, et al.
Published: (2008-03-01)

Understanding IGF-II Action through Insights into Receptor Binding and Activation
by: Andrew J. Blyth, et al.
Published: (2020-10-01)

Targeting Insulin-Like Growth Factor-1 Signaling into the Central Nervous System for Promoting Myelin Repair
by: Nadine Wilczak, et al.
Published: (2008-01-01)

Type 1 insulin-like growth factor receptor (IGF-1R) targeted therapies in pediatric cancer
by: Michael J Wagner, et al.
Published: (2013-02-01)

IGF-binding proteins in type 1 diabetes are more severely altered in the presence of complications
by: Ashok eSharma, et al.
Published: (2016-01-01)

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
by: Stefanie de Groot, et al.
Published: (2020-11-01)

Fibromiyalji Sendromlu Kadın Hastalarda IGF-1’in Klinik Semptomlarla İlişkisi
by: Sevgi Gümüş Atalay
Published: (2018-09-01)

The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling
by: Tomoko Okuyama, et al.
Published: (2021-06-01)

Disrupting Insulin and IGF Receptor Function in Cancer
by: Jingran Cao, et al.
Published: (2021-01-01)

The Relation of IGF-1 and Insulin Resistance in a Sample of Iraqi Obese Type 2 Diabetic Patients with Macrovascular Disease
by: Baghdad Science Journal
Published: (2012-12-01)

Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation
by: Veronica Vella, et al.
Published: (2019-09-01)

Repeated Insulin-like Growth Factor 1 (IGF1) treatment in a patient with Rett Syndrome: a single case study
by: Giorgio ePini, et al.
Published: (2014-06-01)

Elevated serum insulin‐like growth factor 1 in recurrent aphthous stomatitis
by: Lorena Baccaglini, et al.
Published: (2019-06-01)

The Effects of Obesity on the Relationships Among Insulin-like Growth Factor 1 and Markers of Diabetes
by: Moham, Samin
Published: (2010)

Microphysiometry Studies of Rapid Binding of Insulin-Like Growth Factor I by Parental and Transfected Mammary Epithelial Cell Lines
by: Robinson, Rose Marie
Published: (2014)

Cord blood level of insulin-like growth factor-1 and IGF binding protein-3 in monochorionic twins
by: Ru-Jeng Teng, et al.
Published: (2015-04-01)

Quantification of the Binding of Insulin-like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3) Using Surface Plasmon Resonance
by: Cassino, Theresa Rachel
Published: (2014)

Blocking the IGF2BP1-promoted glucose metabolism of colon cancer cells via direct de-stabilizing mRNA of the LDHA enhances anticancer effects
by: Xiang-liang Zhang, et al.
Published: (2021-03-01)

Sensitization and translocation of TRPV1 by insulin and IGF-I
by: Pauza Mary E, et al.
Published: (2005-04-01)

Insulin and IGF-1 in goat milk: influence of the diet
by: F. Rosi, et al.
Published: (2010-01-01)

Suppression of Insulin Secretion by Ghrelin and The Deterioration of Glucose Tolerance in Healthy Children
by: Zena E. NoorAldeen, et al.
Published: (2013-07-01)

Facilitative Glucose Transporter And Its Regulation By Insulin/igf-Like Signaling In Caenorhabditis Elegans
by: Kitaoka, Shun
Published: (2015)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R
by: Caterina Mancarella, et al.
Published: (2018-04-01)

Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1
by: Sylvia Nieuwenhuis, et al.
Published: (2019-11-01)

The Neglected Insulin: IGF-II, a Metabolic Regulator with Implications for Diabetes, Obesity, and Cancer
by: Jeff M. P. Holly, et al.
Published: (2019-10-01)

RME-1 is required for lifespan extension and increased resistance to stresses associated with decreased insulin/IGF-1-like signaling in Caenorhabditis elegans
by: Kim Chul-Kyu, et al.
Published: (2017-01-01)

Preparatory training attenuates drastic response of the insulin-like growth factor binding protein 1 at the point of maximal oxygen consumption in handball players
by: Olgica Nedić, et al.
Published: (2017-09-01)